Dr. Ch. Smerling, 3B Pharmaceuticals GmbH
"...I particularly appreciate Trenzyme's scientific competence and their proactive communication during our collaboration ..."
Site directed mutagenesis services without compromise!
Key benefits:
· Fast turnaround
· No unwanted vector backbone mutations
· Virtually no size limitation
· Works for substitutions / deletions / insertions
Our PCR based technology for mutagenized fragment subcloning eliminates all possible artificial mutations anywhere in the plasmid by ensuring that the construct backbone is never subject to PCR - unlike in QuikChange site directed mutagenesis.
Take your project to the next level with our full service recombinant expression and protein purification or the exact mammalian cell line you need.
Selected projects:
17 mutations parallel in six business days
Single, double and triple target sequence mutation within 10
· business days for a pharmaceutical client in Basel
Generation of six different mutants followed by recombinant
· expression and target protein purification
Returning customers from many countries within Europe
(for more details see our customer testimonials)